Nelarabine 81927-0375-01

Package NDC

81927-0375-01

Product NDC: 81927-0375

Manufacturer: Shorla Oncology Inc.
Dosage Form: Injection
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: August 31, 2025
Listing Expires: December 31, 2026
Application: ANDA214809

Need to source Nelarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Nelarabine	5 mg/mL

Drug Class

Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Selected Package

81927-0375-01Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (81927-375-01) / 75 mL in 1 VIAL, SINGLE-DOSE